June 27, 2012 01:13 AM Eastern Daylight Time. STOCKHOLM, Sweden–(BUSINESS WIRE)–Today more than 1 100 medical professionals and patient advocates from 67 countries are gathering in Stockholm for the 3rd World Psoriasis & Psoriatic Arthritis Conference, arranged by the International Federation of Psoriasis Associations, IFPA. The purpose of the World Psoriasis & Psoriatic Arthritis Conferences is to provide a forum for researchers and clinicians active within the fields of dermatology and rheumatology to present and discuss the most recent developments in research, medicine and technology, pertaining to psoriatic disease. Medical comorbidities that can be associated with psoriasis patients include: Other autoimmune disease, such as inflammatory bowel disorders (eg, Crohn’s disease) Cardiovascular disease Diabetes and other components of metabolic syndrome, stemming from a high incidence. Presented at the 3rd World Psoriasis and Psoriatic Arthritis Conference; June 27-July 1, 2012; Tarallo, Early treatment of psoriatic arthritis is associated with improved outcomes: findings from the etanercept PESTA, in Proceedings of the 3rd World Congress of Psoriasis and Psoriatic Arthritis, Stockholm, Sweden, June 2012.
Rheumatoid Arthritis. PANLAR 2012 Punta Cana Repblica Dominicana. 3rd World Psoriasis & Psoriatic Arthritis Conference 2012: Stockholm Sweden. Abstracts of the 3rd World Psoriasis & Psoriatic Arthritis Conference 2012:. Abstracts of the 3rd World Psoriasis & Psoriatic Arthritis Conference 2012:. Outcome Measures in Psoriasis and Psoriatic Arthritis.
Dr. Rosales Alexander, L